siRNA C5 Anti-C5 Ab / Convertase C3b Inflammation C5a siRNA C5 Anti-C5 Ab / IgG / Anti-C5 Ab / K. Y. A. S. / anti-Fx1a / CVF Serum C5 200 PBS Anti-C5 Ab / PBS Anti-C5 Ab / CC5 C5 12 Terminal Pathway Col Ab / Alnylam Pharmaceuticals / Benny Sorensen1 Alnylam Pharmaceuticals Inc. / Benny Sorensen 1 Alnylam Pharmaceuticals Inc. / /
Country
United States / /
Event
FDA Phase / /
Facility
University Medical School / University of Colorado School / /
IndustryTerm
treatment for patients with PNH and other disorders / /